Bristol-Myers Squibb
BMY
BMY
1,518 hedge funds and large institutions have $63.3B invested in Bristol-Myers Squibb in 2016 Q3 according to their latest regulatory filings, with 109 funds opening new positions, 663 increasing their positions, 547 reducing their positions, and 147 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
26% less first-time investments, than exits
New positions opened: 109 | Existing positions closed: 147
30% less capital invested
Capital invested by funds: $90.9B → $63.3B (-$27.6B)
55% less funds holding in top 10
Funds holding in top 10: 110 → 49 (-61)
Holders
1,518
Holding in Top 10
49
Calls
$1.15B
Puts
$1.38B
Top Buyers
| 1 | +$367M | |
| 2 | +$324M | |
| 3 | +$309M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$267M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$240M |
Top Sellers
| 1 | -$1.46B | |
| 2 | -$538M | |
| 3 | -$528M | |
| 4 |
Brown Advisory
Baltimore,
Maryland
|
-$418M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$361M |